Human embryonic stem cells (hESCs) harbor the capacity to differentiate into all primary human cell types [1], [2], [3] and can be cultivated in vitro indefinitely under specified culture conditions [4].
As such, mTOR inhibitors appear to harbor the capacity to improve responses to RT and selected DNA damage-inducing therapeutics, as well as AR-directed strategies.
To investigate whether IFNβ-producing microglia harbor the capacity to control clearance of myelin debris in the CNS we transplanted IFNβ-producing or non-producing microglia onto cerebellar slice cultures.
MID-domains have a 'nucleotide specificity loop' that is involved in recognition and binding of the 5'phosphate of smRNAs, whereas the PIWI domains harbor the capacity to slice due to their characteristic catalytic tetrad, 'D-E-D-H/D', at the active site [ 4, 9, 10].
These constrictions both govern architecture's normative operations and harbor alternate capacities.
Not simply that each of us harbors the capacity for wrongdoing or that insisting on a divide between good and bad people is itself harmful.
At the trunk level, the developmental potentialities of the NCC are more restricted than in their cephalic counterparts, but, in addition to the neural-melanocytic fate that they exclusively express in vivo, it was clearly shown that they harbor mesenchymal capacities that can be revealed in vitro.
"We do not have a screening method that can identify patients who might harbor such capacities and to be able to selectively study such persons with fMRI and further follow up may help bring more resources to aid their recovery of communication with the outside world," Schiff says.
In addition to self-renewal, CSCs harbors the capacity for differentiation into heterogeneous cell lineages.
Thus, we conclude that the specific inhibition of the DNMT1/DMAP1 interaction is a neutral-tumorigenic-specific inhibition of DNMT1/protein-x interaction harboring the capacity to sensitize cells to TMZ + irradiation-induced cell death.
Therapeutic application of PIs in an autoimmune disease setting is much less explored, despite a clear rationale of (immuno) proteasome involvement in (auto antigen presentation, and PIs harboring the capacity to inhibit the activation of nuclear factor-κB and suppress the release of pro-inflammatory cytokines such as tumor necrosis factor alpha and interleukin-6.
